Neoleukin Therapeutics (NGNE) Profit Margin (2014 - 2024)
Neoleukin Therapeutics (NGNE) profit margin from Dec 31, 2014 to Jun 30, 2024. The current Neoleukin Therapeutics (NGNE) profit margin is -1988.17%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Neoleukin Therapeutics (NGNE)
| Year | Profit Margin | Change |
|---|---|---|
| 2024 | -8079.57% | -97.34% |
| 2021 | -303450.00% | +4367.86% |
| 2020 | -6791.84% | +50.63% |
| 2019 | -4509.09% | +3469.58% |
| 2018 | -126.32% | -97.48% |
| 2017 | -5018.00% | -15.91% |
| 2016 | -5967.74% | -69.97% |
| 2015 | -19872.73% | -25.57% |
| 2014 | -26700.00% | N/A |
Comparison Neoleukin Therapeutics (NGNE) profit margin with competitors
Neoleukin Therapeutics (NGNE) profit margin is -1988.17%.